Related Experiment Videos
Seizure control with clomiphene therapy. A case report.
1Neuroendocrine Section, Charles A. Dana Research Institute, Beth Israel Hospital, Boston, MA 02215.
Archives of Neurology
|February 1, 1988
Summary
Clomiphene citrate therapy stopped clinical seizures in a man with hypogonadotropic hypogonadism. Seizures returned after discontinuing clomiphene, suggesting a potential antiseizure effect.
Area of Science:
- Endocrinology
- Neurology
Background:
- Hypogonadotropic hypogonadism and reproductive dysfunction can be associated with complex health issues.
- Epilepsy presents a significant clinical challenge, particularly when comorbidities are present.
Observation:
- A 36-year-old male patient with a 16-year history of epilepsy and hypogonadotropic hypogonadism experienced complete seizure cessation during six months of clomiphene citrate treatment.
- Seizure recurrence was observed within one month of discontinuing clomiphene therapy.
Findings:
- Clomiphene citrate demonstrated a potential antiseizure effect in this patient.
- Possible mechanisms include enhanced serum levels of antiepileptic drugs, normalization of testosterone, or direct cerebral effects.
Implications:
- This case suggests a potential therapeutic role for clomiphene citrate in managing epilepsy in men with hypogonadotropic hypogonadism.
- Further controlled studies are warranted to investigate the efficacy and mechanisms of clomiphene in epilepsy treatment.